Showing results (11-20 of 62) with videos related to
Sort By:
Pageof 7
World Neurosurgery|March 20, 2022
Use of Three-Dimensional Printed Brain Models During Deep Brain Stimulation Surgery Consultation for Patient Health Literacy: A Randomized Controlled InvestigationLisa Hirt, Drew S Kern, Steven Ojemann, et al.Autoimmunity Reviews|March 7, 2015
Managing unwanted immunogenicity of biologicalsMaureen Deehan, Sandra Garcês, Daniel Kramer, et al.Neurosurgical Review|October 19, 2019
Feasibility, safety, and utility of brain MRI for patients with non-MRI-conditioned CIEDJulie Mayeku, Daniel Kramer, Anand Mahadevan, et al.The Journal of Organic Chemistry|May 29, 2008
A domino annulation reaction under Willgerodt-Kindler conditionsDaniel Kadzimirsz, Daniel Kramer, Lertnarong Sripanom, et al.Physical Therapy|June 29, 2002
The experience of providing physical therapy in a changing health care environmentRosemary Blau, Sarah Bolus, Terrence Carolan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2021
The Neurophysiological Representation of Imagined Somatosensory Percepts in Human CortexLuke Bashford, Isabelle Rosenthal, Spencer Kellis, et al.The AAPS Journal|January 8, 2026
Anti-drug Antibody Validation Testing and Reporting Harmonization AddendumHeather Myler, Johanna Mora, Joao Pedras-Vasconcelos, et al.Respirology (Carlton, Vic.)|August 3, 2023
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosisJoy Zhao, Joseph Fares, Gautam George, et al.Journal of Reproductive Immunology|May 11, 2010
Divergent immunomodulatory effects of recombinant and urinary-derived FSH, LH, and hCG on human CD4+ T cellsFortunata Carbone, Claudio Procaccini, Veronica De Rosa, et al.Anti-Cancer Drugs|August 22, 2015
Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancerOleg Gladkov, Rodryg Ramlau, Piotr Serwatowski, et al.Pageof 7